Header Logo

Connection

Mandisa Singata-Madliki to Norethindrone

This is a "connection" page, showing publications Mandisa Singata-Madliki has written about Norethindrone.
Connection Strength

1,244
  1. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. PLoS One. 2024; 19(3):e0295764.
    View in: PubMed
    Score: 0,919
  2. The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial. PLoS One. 2024; 19(8):e0307736.
    View in: PubMed
    Score: 0,236
  3. Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN. PLoS One. 2023; 18(12):e0295959.
    View in: PubMed
    Score: 0,056
  4. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. Reprod Health. 2016 Apr 18; 13:42.
    View in: PubMed
    Score: 0,033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.